Comment on CFTC-2026-1321, CFTC-2026-1321-0001, CME Group
CME GroupOtherBusiness
Summary: CME Group Inc. argues that while the Commission should facilitate innovation, it must not do so at the expense of risk management, market integrity, or customer protection. The commenter warns against removing regulatory "impediments" that would allow unregistered firms to conduct activities that traditionally require registration.
See attached file(s)